Variable | All patients | <80 mg/dL | 80–120 mg/dL | 121–150 mg/dL | 151–200 mg/dL | >201 mg/dL | P value |
---|---|---|---|---|---|---|---|
n | 230 | 32 | 53 | 38 | 23 | 84 | Â |
Age (years ± SD) | 66 ± 17 | 63 ± 17 | 59 ± 25 | 70 ± 15 | 70 ± 13 | 66 ± 16 | 0.08 |
Gender (M:F) % | 53:47 | 44:56 | 68:32 | 50:50 | 56:44 | 49:51 | 0.18 |
Race, n (%) | Â | Â | Â | Â | Â | Â | Â |
AA | 201(87) | 31(97) | 47(89) | 32(84) | 20(87) | 71(85) | 0.56 |
Caucasian | 26(11) | 1(3) | 6(11) | 5(13) | 3(13) | 11(13) | |
Other | 3(1) | Â | Â | 1(3) | Â | 2(2) | |
Pre-existing conditions, n (%) | Â | Â | Â | Â | Â | Â | Â |
Hypertension | 153(67) | 22(69) | 29(54) | 25(64) | 14(61) | 63(74) | 0.2 |
COPD | 34(15) | 5(16) | 6(11) | 10(26) | 3(13) | 10(12) | 0.3 |
CHF | 82(36) | 12(37) | 22(41) | 12(31) | 10(43) | 26(31) | 0.6 |
Diabetes Mellitus | 57(25) | 2(6) | 3(6) | 2(5) | 4(17) | 46(54) | 0.0001 |
Liver failure | 63(27) | 10(31) | 18(33) | 8(20) | 5(22) | 22(26) | 0.6 |
Renal failure | 33(14) | 6(19) | 6(11) | 7(18) | 3(13) | 11(13) | 0.8 |
APACHE II, mean ± SD | 22 ± 7 | 24 ± 7 | 19 ± 6 | 22 ± 7 | 24 ± 7 | 21 ± 7 | 0.019 |